Drug allergy laboratory findings: Difference between revisions
Jump to navigation
Jump to search
| Line 16: | Line 16: | ||
* [[Histamine]] levels may be elevated after an acute reaction, but is unreliable for [[diagnosis]]. | * [[Histamine]] levels may be elevated after an acute reaction, but is unreliable for [[diagnosis]]. | ||
* [[Skin testing]] for drug-specific [[IgE]]. Only for type I allergic reactions. | * [[Skin testing]] for drug-specific [[IgE]]. Only for type I allergic reactions. | ||
* In-vitro tests for immediate drug reactions are available, but are largely considered investigational. | * [[In-vitro]] tests for immediate drug reactions are available, but are largely considered investigational. | ||
*Patch testing to test for a type IV reaction where drugs are mixed into petrolatum and applied to the skin for 48 hours. This test is useful in evaluating patients with maculopapular exanthema, acute generalized exanthematous pustulosis, and flexular exanthema. It is not to be used in patients with a history of Stevens-johnson syndrome or toxic epidermal necrolysis. | *Patch testing to test for a type IV reaction where drugs are mixed into petrolatum and applied to the skin for 48 hours. This test is useful in evaluating patients with maculopapular exanthema, acute generalized exanthematous pustulosis, and flexular exanthema. It is not to be used in patients with a history of Stevens-johnson syndrome or toxic epidermal necrolysis. | ||
* Intradermal testing with delayed readout is more | * Intradermal testing with delayed readout is more sensitive than a patch test, and involves [[injection]] of a small amount of the allergen dissolved in water, under the skin. A prick test should be done beforehand, and the concentration used should be non-irritating. | ||
Revision as of 19:22, 13 August 2012
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Charmaine Patel, M.D. [2]
|
Drug Allergy |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Drug allergy laboratory findings On the Web |
|
American Roentgen Ray Society Images of Drug allergy laboratory findings |
|
Risk calculators and risk factors for Drug allergy laboratory findings |
Overview
Laboratory Findings
- Erythrocyte sedimentation rate (ESR) may be increased.
- White blood cell (WBC) may be increased.
- Urine eosinophils may be increased, especially in cases of allergic interstitial nephritis.
- Blood eosinophils may be increased.
- Liver function tests (LFT)'s may be increased.
- Elevations in tryptase may be seen detected in serum or plasma within several hours after an acute allergic event, and is consistent with anaphylaxis.
- Histamine levels may be elevated after an acute reaction, but is unreliable for diagnosis.
- Skin testing for drug-specific IgE. Only for type I allergic reactions.
- In-vitro tests for immediate drug reactions are available, but are largely considered investigational.
- Patch testing to test for a type IV reaction where drugs are mixed into petrolatum and applied to the skin for 48 hours. This test is useful in evaluating patients with maculopapular exanthema, acute generalized exanthematous pustulosis, and flexular exanthema. It is not to be used in patients with a history of Stevens-johnson syndrome or toxic epidermal necrolysis.
- Intradermal testing with delayed readout is more sensitive than a patch test, and involves injection of a small amount of the allergen dissolved in water, under the skin. A prick test should be done beforehand, and the concentration used should be non-irritating.